Search details
1.
Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study.
Gastric Cancer
; 26(6): 1020-1029, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37610558
2.
Treatments for elderly cancer patients and reforms to social security systems in Japan.
Int J Clin Oncol
; 27(2): 310-315, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-35098370
3.
[Oncology in Super-Aged Society].
Gan To Kagaku Ryoho
; 49(1): 8-12, 2022 Jan.
Article
in Japanese
| MEDLINE | ID: mdl-35046352
4.
Second-line pembrolizumab versus chemotherapy in Japanese patients with advanced esophageal cancer: subgroup analysis from KEYNOTE-181.
Esophagus
; 19(1): 137-145, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34591237
5.
Multicenter Phase II Trial of Axitinib Monotherapy for Gemcitabine-Based Chemotherapy Refractory Advanced Biliary Tract Cancer (AX-BC Study).
Oncologist
; 26(2): 97-e201, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33010112
6.
Protocol for a multi-site, cluster-randomized, phase III, comparative clinical trial of geriatric assessment of older patients with non-small-cell lung cancer: the ENSURE-GA study.
BMC Geriatr
; 21(1): 74, 2021 01 22.
Article
in English
| MEDLINE | ID: mdl-33482741
7.
First-in-human phase I study of JPH203, an L-type amino acid transporter 1 inhibitor, in patients with advanced solid tumors.
Invest New Drugs
; 38(5): 1495-1506, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32198649
8.
Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results.
BMC Cancer
; 20(1): 1105, 2020 Nov 16.
Article
in English
| MEDLINE | ID: mdl-33198671
9.
Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology.
Int J Clin Oncol
; 25(3): 403-417, 2020 Mar.
Article
in English
| MEDLINE | ID: mdl-31974683
10.
Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer.
Cancer Sci
; 110(11): 3565-3572, 2019 Nov.
Article
in English
| MEDLINE | ID: mdl-31520559
11.
Phase II trial of aflibercept with FOLFIRI as a second-line treatment for Japanese patients with metastatic colorectal cancer.
Cancer Sci
; 110(3): 1032-1043, 2019 Mar.
Article
in English
| MEDLINE | ID: mdl-30657223
12.
Impact of Advanced Age on Survival in Patients Undergoing Resection of Hepatocellular Carcinoma: Report of a Japanese Nationwide Survey.
Ann Surg
; 269(4): 692-699, 2019 04.
Article
in English
| MEDLINE | ID: mdl-28922205
13.
First-in-human phase 1 study of novel dUTPase inhibitor TAS-114 in combination with S-1 in Japanese patients with advanced solid tumors.
Invest New Drugs
; 37(3): 507-518, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30511200
14.
Geriatric Research Policy: Japan Clinical Oncology Group (JCOG) policy.
Jpn J Clin Oncol
; 49(10): 901-910, 2019 Oct 01.
Article
in English
| MEDLINE | ID: mdl-31565730
15.
Ramucirumab for the treatment of metastatic gastric or gastroesophageal junction adenocarcinoma following disease progression on first-line platinum- or fluoropyrimidine-containing combination therapy in Japanese patients: a phase 2, open-label study.
Gastric Cancer
; 21(6): 1041-1049, 2018 11.
Article
in English
| MEDLINE | ID: mdl-29508095
16.
ï¼Editors' Choiceï¼ Practice management for elderly patients with breast cancer; Findings from a survey by the Japan Breast Cancer Study Group.
Nagoya J Med Sci
; 80(2): 217-226, 2018 May.
Article
in English
| MEDLINE | ID: mdl-29915439
17.
[The Risk Factors of Cancer Chemotherapy in Elderly Patients].
Gan To Kagaku Ryoho
; 45(1): 8-11, 2018 Jan.
Article
in Japanese
| MEDLINE | ID: mdl-29362297
18.
Treatment selection for esophageal cancer: evaluation from a nationwide database.
Esophagus
; 15(2): 109-114, 2018 04.
Article
in English
| MEDLINE | ID: mdl-29892936
19.
Emerging protein kinase inhibitors for treating pancreatic cancer.
Expert Opin Emerg Drugs
; 22(1): 77-86, 2017 03.
Article
in English
| MEDLINE | ID: mdl-28253828
20.
[Geriatric Oncology].
Gan To Kagaku Ryoho
; 44(2): 97-101, 2017 Feb.
Article
in Japanese
| MEDLINE | ID: mdl-28223666